[Retinal cryocoagulation in rubeosis iridis].
Patients with neovascularization of the iris were treated with cryocoagulation of the peripheral retina alone (Group A, n = 29), or in combination with cryocoagulation of the ciliary body (Group B, n = 19). The basic disease was either diabetic retinopathy or occlusion of the central retinal vein. After a follow-up of at least six months, a marked reduction in neovascularization of the iris was seen in most eyes. Intraocular pressure was reduced from a mean of 35.4 to 13.4 mm Hg in Group A, and from 55,2 to 6 mm Hg in Group B. A phthisis bulbi developed in six of 30 eyes (20%) in Group A and in 11 of 20 eyes (55%) in Group B.
Schildwächter
A
A
Univ. Augenklinik Freiburg, Abteilung für Neuroophthalmologie und Schielbehandlung.
Witschel
H
H
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003452:Cryosurgery; D003930:Diabetic Retinopathy / Q000601:surgery; D005500:Follow-Up Studies; D006801:Humans; D007429:Intraocular Pressure; D007498:Iris / Q000098:blood supply*; D008875:Middle Aged; D009389:Neovascularization, Pathologic / Q000601:surgery*; D012170:Retinal Vein Occlusion / Q000601:surgery; D012171:Retinal Vessels / Q000601:surgery*; D014792:Visual Acuity
Netzhautkryokoagulation bei Rubeosis iridis.